Please login to the form below

Not currently logged in
Email:
Password:

Zuranolone

This page shows the latest Zuranolone news and features for those working in and with pharma, biotech and healthcare.

Biogen signs $3.1bn deal with Sage for potential depression therapies

Biogen signs $3.1bn deal with Sage for potential depression therapies

Outside the US, Biogen will hold responsibility for development and commercialisation with respect to zuranolone, excluding Japan, Taiwan and South Korea. ... Zuranolone is currently being studied in phase 3 development and has already picked up a

Latest news

More from news
Approximately 2 fully matching, plus 0 partially matching documents found.

PMEA Awards 2020

COVID-19 Updates and Daily News

Featured jobs

PMHub

Add my company
Wisepress

Wisepress is a medical bookseller promoting and selling books worldwide, both online and via the 200 European medical conferences that...

Latest intelligence

PME Jan cover
AstraZeneca’s focus on diagnosing and managing chronic kidney disease
People living with chronic kidney disease are in urgent need of new and improved approaches to diagnosis and care...
Delphi Technique Virtual Co-creation: A Customer Story
How a client leveraged the Delphi technique to co-create a consensus statement and algorithm using virtual touchpoints....
AI healthcare
Three ways AI will change healthcare in the next decade
Looking forward, there is no doubt that AI will continue to take centre stage in global healthcare initiatives...

Infographics